The expanding role of prodrugs in contemporary drug design and development

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature reviews. Drug discovery

• Publication date

  2018-04-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nrd.2018.46PMID 29700501
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir.

  2018cited by this paper
• Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma

  2017cited by this paper
• Recent advances in macromolecular prodrugs

  2017cited by this paper
• Pharmacologic and Pharmacokinetic Aspects Lisdexamfetamine dimesylate is a water-soluble prodrug of the single isomer—d-amphetamine and l-lysine—that remains Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

  2017cited by this paper
• Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.

  2017cited by this paper
• Prodrug strategy for cancer cell-specific targeting: A recent overview.

  2017cited by this paper
• Prodrugs – Recent approvals and a glimpse of the pipeline

  2017cited by this paper
• Reaction phenotyping to assess victim drug-drug interaction risks

  2017cited by this paper
• In Vitro-In Vivo Extrapolation of Intestinal Availability for Carboxylesterase Substrates Using Portal Vein-Cannulated Monkey.

  2017cited by this paper
• Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations

  2017cited by this paper
• 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer

  2017cited by this paper
• Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites

  2017cited by this paper
• Immunotherapy for head and neck cancer: the future of treatment?

  2017cited by this paper
• The ProTide Prodrug Technology: From the Concept to the Clinic

  2017cited by this paper
• Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.

  2017cited by this paper
• Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination

  2017cited by this paper
• Antibody Drug Conjugates for Cancer Therapy

  2016cited by this paper
• Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF).

  2016cited by this paper
• Critical evaluation of latanoprostene bunod in the treatment of glaucoma

  2016cited by this paper
• Isavuconazonium sulfate for the treatment of fungal infection.

  2016cited by this paper
• Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.

  2016cited by this paper
• Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery

  2016cited by this paper
• Selexipag: First Global Approval

  2016cited by this paper
• Proteases in cancer drug delivery.

  2016cited by this paper
• Textbook of drug design and discovery

  2016cited by this paper
• Antibody–Drug Conjugates for Cancer Therapy

  2016cited by this paper
• Lisdexamfetamine: A pharmacokinetic review.

  2016cited by this paper
• Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

  2016cited by this paper
• Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.

  2016cited by this paper
• Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.

  2016cited by this paper
• Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia.

  2016cited by this paper
• Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy

  2016cited by this paper
• The codrug approach for facilitating drug delivery and bioactivity

  2016cited by this paper
• A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children

  2016cited by this paper
• Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes.

  2015cited by this paper
• Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents.

  2015cited by this paper
• CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors

  2015cited by this paper
• Antibody Drug Conjugates: Design and Selection of Linker, Payload and Conjugation Chemistry

  2015cited by this paper
• Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.

  2015cited by this paper
• Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics

  2015cited by this paper
• Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension

  2015cited by this paper
• Quantitative Assessment of Intestinal First-pass Metabolism of Oral Drugs Using Portal-vein Cannulated Rats

  2015cited by this paper
• Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors

  2015cited by this paper
• NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

  2015cited by this paper
• Principles in the design of ligand-targeted cancer therapeutics and imaging agents

  2015cited by this paper
• Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

  2015cited by this paper
• Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure

  2015cited by this paper
• Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies.

  2015cited by this paper
• Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug

  2014cited by this paper
• Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

  2014cited by this paper
• Proteases as activators for cytotoxic prodrugs in antitumor therapy.

  2014cited by this paper
• Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development.

  2014cited by this paper
• Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs

  2014cited by this paper
• Identification of Carboxylesterase-Dependent Dabigatran Etexilate Hydrolysis

  2014cited by this paper
• Gene-Directed Enzyme Prodrug Therapy

  2014cited by this paper
• Enabled clinical use of an HIV-1 attachment inhibitor through drug delivery.

  2014cited by this paper
• Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.

  2014cited by this paper
• Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects

  2014cited by this paper
• Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition

  2014cited by this paper
• The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?

  2013cited by this paper
• Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil

  2013cited by this paper
• Polymer therapeutics-prospects for 21st century: the end of the beginning.

  2013cited by this paper
• PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

  2013cited by this paper
• Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer

  2013cited by this paper
• Pharmaceutics, Drug Delivery and Pharmaceutical Technology Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug

  2013cited by this paper
• Amino acids as promoieties in prodrug design and development.

  2013cited by this paper
• Drug transport via the intestinal peptide transporter PepT1.

  2013cited by this paper
• Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach.

  2013cited by this paper
• Cytochrome P450-activated prodrugs.

  2013cited by this paper
• Glutathione Transferase (GST)-Activated Prodrugs

  2013cited by this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cited by this paper
• The Discovery of Dabigatran Etexilate

  2012cited by this paper
• Parecoxib (Parecoxib Sodium)

  2012cited by this paper
• Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)

  2012cited by this paper
• Overcoming poor permeability - the role of prodrugs for oral drug delivery.

  2012cited by this paper
• Dabigatran Etexilate

  2012cited by this paper
• A Semiphysiologically Based Pharmacokinetic Modeling Approach to Predict the Dose-Exposure Relationship of an Antiparasitic Prodrug/Active Metabolite Pair

  2012cited by this paper
• Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.

  2012cited by this paper
• Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.

  2012cited by this paper
• Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications

  2012cited by this paper
• Species difference of esterase expression and hydrolase activity in plasma.

  2012cited by this paper
• Gemtuzumab Ozogamicin

  2012cited by this paper
• Adefovir Dipivoxil

  2012cited by this paper
• Fospropofol

  2012cited by this paper
• Differential pharmacology and benefit/risk of azilsartan compared to other sartans

  2012cited by this paper
• Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms.

  2012cited by this paper
• Levodopa: A Review of its Pharmacological Properties and Therapeutic Uses with Particular Reference to Parkinsonism

  2012cited by this paper
• Use of enzyme inhibitors to evaluate the conversion pathways of ester and amide prodrugs: a case study example with the prodrug ceftobiprole medocaril.

  2012cited by this paper
• Bridging solubility between drug discovery and development.

  2012cited by this paper
• Oseltamivir

  2012cited by this paper
• Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.

  2011cited by this paper
• Prodrugs Designed to Target Transporters for Oral Drug Delivery

  2011cited by this paper
• Enzyme-mediated hydrolytic activation of prodrugs

  2011cited by this paper
• Directed Enzyme Prodrug Therapies

  2011cited by this paper
• Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma

  2011cited by this paper
• Modulating Solubility Through Prodrugs for Oral and IV Drug Delivery

  2011cited by this paper
• Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation

  2011cited by this paper
• Polymer therapeutics as nanomedicines: new perspectives.

  2011cited by this paper
• Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.

  2011cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper

• Metabolic Stability of Fluorinated Small Molecules: A Physical Organic Chemistry Perspective.

  2026cites this paper
• Prodrug strategies in developing antiviral nucleoside analogs

  2026cites this paper
• Oral anticancer drug delivery: Strategies for improving bioavailability

  2026cites this paper
• Photoinduced Silver(I)‐Mediated Direct Alkoxycarbonylation of Quinoxalin‐2(1 H )‐ones With Alkyloxalyl Chlorides

  2026cites this paper
• Spatiotemporal control of prodrug activation through external stimuli for effective and safe on-site release in solid tumors: From current advances to future perspectives.

  2026cites this paper
• The zebrafish in toxicology: a bibliometric analysis reveals current trends and future avenues for predictive safety assessment

  2026cites this paper
• Emerging therapeutic drug targets in amino acid and protein biosynthesis pathways against ESKAPE and non-ESKAPE pathogens: a comprehensive review

  2026cites this paper
• A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

  2026cites this paper
• A Novel Tertiary Carbamate Prodrug Strategy to Overcome Metabolic Barriers in Oral Ketamine Delivery

  2026cites this paper
• Improving Laboratory-Based Cancer Drug Discovery Study Designs for Better Research Translations

  2026cites this paper
• Prodrug-ML: prodrug-likeness prediction via machine learning on sampled negative decoys

  2026cites this paper
• Design of prodrugs with reactive oxygen species as activators and their application in tumor therapy

  2026cites this paper
• Acetal Prodrug Self-Assembly Based on Salicylaldehyde for Efficient Management of Plant Disease and Postharvest Preservation

  2026cites this paper
• Self‐Carrier Nanovaccines Codelivering Paclitaxel and Tumor Cell Lysates for Enhanced Antitumor Chemo‐Immunotherapy

  2026cites this paper
• Targeting metabolic vulnerabilities with advanced delivery systems.

  2026cites this paper
• Kinetic and biocatalytic evaluation of dodecyl nicotinate hydrolysis in aqueous buffers and biological media

  2026cites this paper
• Enhancing the Oral Bioavailability of a Poorly Soluble Pan-CK2 Kinase Inhibitor: Leveraging a Phosphate Prodrug Strategy to Overcome Dissolution-Limited Absorption and Improve Systemic Exposure during Dose Escalation.

  2026cites this paper
• Pd-Catalyzed Asymmetric Allylic Alkylation of Carboxylic Acids for the Synthesis of Chiral Butenolidyl Ester Prodrugs and Peptide-Drug Conjugates.

  2025cites this paper
• Cyclodextrin Complexes for Clinical Translatability: Applications for Cladribine and Retrometabolically Designed Estredox

  2025cites this paper
• Preclinical Pharmacological and Toxicological Evaluation of SB5794, a Novel Aryl Hydrocarbon Receptor Modulator on the Kynurenine–AhR Axis

  2025cites this paper
• Galactose-modified small molecule modulator targets RORα to enhance circadian rhythm and alleviate periodontitis-associated alveolar bone loss

  2025cites this paper
• delta-8-THC Acetate-A Prodrug of delta-8-THC?: A Case Report

  2025cites this paper
• Prodrug strategy: molecular design for improving oral drug absorption.

  2025cites this paper
• Bioorthogonally activatable methylene blue platform for selective prodrug activation and fluorescent imaging in living systems.

  2025cites this paper
• Glutathione-activated prodrug-based self-delivering nanomedicines for tumoricidal chemo-photodynamic synergistic therapy.

  2025cites this paper
• Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy.

  2025cites this paper
• New UHPLC-MS/MS method for simultaneously determination of cis-trans isomers N-isobutyl-2E,4E,8Z,10E/Z-dodecatetraenamide from Asari Radix and the differential metabolites in rat plasma: Application in metabolic stability and pharmacokinetics study.

  2025cites this paper
• Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells

  2025cites this paper
• Design, synthesis, biological and computational evaluation of novel S/N-glycerolyl and peptide-conjugated [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent CDK2 inhibitors for anticancer therapy.

  2025cites this paper
• Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy

  2025cites this paper
• Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy

  2025cites this paper
• Exploring prodrug approaches for Alzheimer's treatment: an overview.

  2025cites this paper
• Enantioselective Alkoxycarbonyl‐Lactonization of Alkenes via the Merger of Photoredox and Copper Catalysis

  2025cites this paper
• Antibody–drug conjugates in breast cancer: mechanisms of resistance and future therapeutic perspectives

  2025cites this paper
• A self-assembled and H2O2-activatable hybrid nanoprodrug for lung infection and wound healing therapy

  2025cites this paper
• Unveiling the Phytochemical Profiling by Chromatographic and Spectrometric Techniques and the Bioactive Potential of Rumex vesicarius L.

  2025cites this paper
• Exploring therapeutic and diagnostic potential of cysteine cathepsin as targets for cancer therapy with nanomedicine.

  2025cites this paper
• Modular molecular design of polymerized pro-estrogen materials enables controlled astrocyte response

  2025cites this paper
• Prodrugs Targeting Prostate-Specific Membrane Antigen against Prostate Cancer

  2025cites this paper
• Discovery of 2-Ethynylisoborneol as a Highly Potent Anti-seizure Agent.

  2025cites this paper
• Translational PBPK/PD modeling in drug discovery: A CRO perspective.

  2025cites this paper
• Novel agents inhibiting the Marburg nucleoprotein using molecular docking, ADMET, MD, and quantum DFT methods

  2025cites this paper
• Celecoxib Reimagined: Multifunctional Roles in Advanced Drug Delivery and Therapeutics

  2025cites this paper
• Improved Synthesis of a Sub-Nanomolar Vinyl Phosphonate Inhibitor of Dehydroquinate Synthase

  2025cites this paper
• Structural Optimization to Synthesize Tri‐Aryl Acetate‐Based Scaffolds and Probing Distinct Druggable Binding Sites to Describe Biological Target

  2025cites this paper
• Histone modifications: Unveiling the epigenetic enigma of degenerative skeletal diseases

  2025cites this paper
• Prodrug-based drug delivery systems: strategic approaches and emerging challenges in targeted therapeutics.

  2025cites this paper
• Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms

  2025cites this paper
• Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA.

  2025cites this paper
• Synthesis, In vitro Characterization and Biopharmaceutical Evaluation of a Novel Phosphate Prodrug of Sorafenib.

  2025cites this paper
• Plasma pre-incubation: Concentration-dependent regulation of the biomolecular corona on PEGylated liposome and cellular uptake.

  2025cites this paper
• Bioorthogonal Chemistry: An Emerging Strategy for Targeted Protein Degradation.

  2025cites this paper
• Discovery of a novel 4-pyridyl SLC-0111 analog targeting tumor-associated carbonic anhydrase isoform IX through tail-based design approach with potent anticancer activity

  2025cites this paper
• Medoxomil Prodrug Strategies.

  2025cites this paper
• Kinetic Stability of Amorphous Glasses of New Sulfonamide-Based Prodrugs According to Differential Scanning Calorimetry Data

  2025cites this paper
• Novel O-methylpyrimidine prodrugs of phenolic compounds bioactivated by aldehyde oxidase: Enhancing metabolic stability against first-pass conjugative metabolism in the intestine.

  2025cites this paper
• GSH‐Responsive Semiconducting Polymer as a Nanotheranostic Platform for NIR‐II Imaging‐Guided Chemo‐Photothermal Therapy

  2025cites this paper
• ROS-responsive simvastatin nano-prodrug based on tertiary amine-oxide zwitterionic polymer for atherosclerotic therapy

  2025cites this paper
• Small Molecule Drugs Triggered the Activation of Macrocycle Masked Proteins.

  2025cites this paper
• Prodrugs and their activation mechanisms for brain drug delivery

  2025cites this paper
• The Cascade Reaction Chemistry of Diazo Compounds with Intentionally Designed Alkene to Access Esterified Heterocycles.

  2025cites this paper
• Ester derivatives of Dictyostelium differentiation-inducing factors exhibit antibacterial activity, possibly via a prodrug-like function

  2025cites this paper
• Discovery of 3-hydroxypyridin-4(1H)-ones ester of ciprofloxacin as prodrug to combat biofilm-associated Pseudomonas aeruginosa.

  2025cites this paper
• Photocatalytic Regioselective Alkoxycarbonylation/Cyclization of 3-Aza-1,5-dienes: Access to Ester-Containing Pyrrolin-2-ones.

  2025cites this paper
• Antibody Drug Conjugates (ADCs): Shaping the Future of Precision Oncology.

  2025cites this paper
• Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport.

  2025cites this paper
• Prodrug Approach as a Strategy to Enhance Drug Permeability

  2025cites this paper
• Synthesis of Enantiostructured Triacylglycerol Prodrugs Constituting an Active Drug Located at Terminal sn-1 and sn-3 Positions of the Glycerol Backbone

  2025cites this paper
• Self-Accelerated Nanoregulators for Positive Feedback Ferroptosis-Immunotherapy.

  2025cites this paper
• Polymeric PEG-based bioorthogonal triggers for prodrug activation in breast cancer

  2025cites this paper
• Preliminary evaluation of the in vitro and in vivo efficacy of a novel nanovesicle-doped nanoemulsion co-loading artemisinin and quercetin as a promising strategy to improve the oral malaria therapy

  2025cites this paper
• Synthesis of Ester-Substituted Polycyclic N-Heteroaromatics via Photocatalyzed Alkoxycarbonylation/Tricyclization Reactions of Enediyne in Continuous Flow Conditions.

  2025cites this paper
• Synthesis of Prodrug‐Type Oligonucleotides Modified With a Galactosylated Self‐Immolative Linker Cleavable by β‐Galactosidase

  2025cites this paper
• Carrier-free nano-prodrugs for enhanced cancer therapy: stimuli-responsive design and applications

  2025cites this paper
• 3D Hepatocyte Model with Composite Nanofibers That Reproduced Human In Vivo Drug Clearance Profiles.

  2025cites this paper
• Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles

  2025cites this paper
• Strategy‐Level Prodrug Synthesis

  2025cites this paper
• Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell lines.

  2025cites this paper
• Photo-bioactivated azido fluorophores for passive and active cell imaging

  2025cites this paper
• Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates

  2025cites this paper
• Advances in drug design and discovery: A Comprehensive Review

  2025cites this paper
• Machine learning for predicting drug-drug interactions: graph neural networks and beyond

  2025cites this paper
• Design and Characterization of Prodrugged Anti‐CTLA‐4 Antibodies

  2025cites this paper
• Manganese(III)-Mediated Chemoselective Radical Coupling of Diarylphosphine Oxides and Tetrasulfides: Synthesis of Dithiophosphates and Thiophosphates.

  2025cites this paper
• Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy

  2025cites this paper
• РОЗРОБКА РЕЦЕПТУРИ ОПОЛІСКУВАЧА «МЕТРАСТОМХІТГІАЛ» ЯК ЗАСОБУ ПОТЕНЦІЙНОГО ВПЛИВУ НА МІКРОБІОМ І РЕГЕНЕРАЦІЮ ТКАНИН ПОРОЖНИНИ РОТА ЗА НАЯВНОСТІ ПОСТ-COVID-19-СИНДРОМУ

  2025cites this paper
• Small Molecule-Degrader Conjugates: Evaluating the Structure-Activity Relationship of Linkers to Overcome In Vivo Barriers in PROTAC Delivery.

  2025cites this paper
• Esterase-induced release of a theranostic prodrug in lysosomes for improved therapeutic efficacy and lower systemic toxicity

  2025cites this paper
• A Dual-Functional Prodrug for Imaging and Eradication of Drug-Resistant Gram-Negative Bacteria.

  2025cites this paper
• Advanced Drug Delivery Strategies to Overcome Solubility and Permeability Challenges: Driving Biopharmaceutical Advancements Toward Commercial Success

  2025cites this paper
• Enzyme-Responsive Metallopeptide Hydrogel Enables Cancer Cell-Selective Prodrug Activation via Bioorthogonal Catalysis.

  2025cites this paper
• The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo

  2025cites this paper
• Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals with Binary Lipid Systems and Evaluating the Influence of Compositions

  2025influential citation
• Nanotechnology-based strategies for overcoming clinical limitations of PROTACs in cancer therapy.

  2025cites this paper
• Engineering natural arginine finger to deliver phosphate-containing drugs for treating osteoarthritis

  2025cites this paper
• Wet Media Milling Preparation and Process Simulation of Nano-Ursolic Acid

  2025cites this paper
• Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.

  2024cites this paper
• Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation.

  2024cites this paper
• Medicines management in children and young people: pharmacological approaches to treat pain.

  2024cites this paper
• Multitasking Pharmacophores Support Cabotegravir-Based Long-Acting HIV Pre-Exposure Prophylaxis (PrEP)

  2024cites this paper